Indication
Colistin Resistant ABC
1 clinical trial
4 products
Product
SulbactamClinical trial
A Randomized, Active-controlled Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus ComplexStatus: Completed, Estimated PCD: 2021-07-26
Product
ColistinProduct
DurlobactamProduct
Imipenem/Cilastatin